Skip to Content

  • Search

View Additional Section Content

Randomized, Open-Label, Phase 3 Study of Pemetrexed plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab versus Paclitaxel plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non-Small Cell Lung Cancer

Principal Investigator(s)
Pallav Mehta, M.D.
Robert A. Maxwell, M.D. (Sub-Investigator)
Peter V. Pickens, M.D. (Sub-Investigator)
Joseph L. Potz, M.D. (Sub-Investigator)
Marc J. Chernoff, D.O. (Sub-Investigator)
Vishwanath Gharpure, M.D. (Sub-Investigator)
Jason A. Damsker, M.D. (Sub-Investigator)
Felice LePar, M.D. (Sub-Investigator)
Michael J. Seidman, M.D. (Sub-Investigator)
Jessica A. Berman, M.D. (Sub-Investigator)

Clinical Trial Categories

  • Lung Cancer
Contact
Diane Foley, CCRP at 215-692-3213

Location

  • Abington Hematology/Oncology Associates
    Abington Health Center - Schilling
    2510 Maryland Rd, Ste 175
    Willow Grove, PA 19090-1108
    Office: 215-706-2034
    Fax: 215-706-4176

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details